Amgen Inc.
時価総額
$229.5B
世界順位
#63
過去最高値
$229.5B
2026-08-18
総成長率
+0%
2026年以降
Market Cap Context
- Larger than 83% of the 367 companies we track (globally).
- Equivalent to 0.7% of United States's GDP (2025 data).
- Just above: #62 LVMH Moët Hennessy - Louis Vuitton, Société Européenne ($238.4B)
- Just below: #64 American Express Company ($228.6B)
- Best year: 1999 (+130%). Worst year: 2007 (-32%).
Amgen Inc. Financial Breakdown (FY 2025)
Source: Yahoo Finance — AMGN annual filings (2025) →$36.8B revenue · $9.1B operating income · $7.7B net income
- ●Operating margin: 24.7% on $36.8B in revenue.
- ●R&D is 19.8% of revenue ($7.3B).
- ●Net income margin: 21.0% — $7.7B in profit.
- ●Free cash flow: $8.1B (22.0% of revenue).
Cost / Operating Expenses
Total operating expenses $27.7B
Total
$26.4B
Capital Expenditures
$1.9B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$8.1B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Amgen Inc.について
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
Amgen Inc.の時価総額推移 (2026–2026)
Amgen Inc. vs Sector Peers by Market Cap
Amgen Inc.を比較
順位の推移
| 年 | 時価総額 | 順位 | 前年比 |
|---|---|---|---|
| 2026 | $229.5B | #63(↑19) | +31.8% |
| 2025 | $174.1B | #82(↑15) | +29.7% |
| 2024 | $134.3B | #97(↓27) | -6.8% |
| 2023 | $144.0B | #70(↓4) | +13.5% |
| 2022 | $126.9B | #66(↑30) | +20.4% |
| 2021 | $105.4B | #96(↓18) | +0.9% |
| 2020 | $104.5B | #78(↓13) | -2.0% |
| 2019 | $106.6B | #65(↓9) | +27.6% |
| 2018 | $83.6B | #56(↑12) | +15.2% |
| 2017 | $72.5B | #68(↑1) | +22.3% |
| 2016 | $59.3B | #69(↓12) | -7.6% |
| 2015 | $64.2B | #57(↑1) | +4.0% |
| 2014 | $61.7B | #58(↑14) | +42.3% |
| 2013 | $43.4B | #72(↑6) | +34.8% |
| 2012 | $32.2B | #78(↑8) | +36.8% |
| 2011 | $23.5B | #86(↑28) | +18.2% |
| 2010 | $19.9B | #114(↓22) | -3.0% |
| 2009 | $20.5B | #92(↓27) | -2.0% |
| 2008 | $20.9B | #65(↑68) | +24.4% |
| 2007 | $16.8B | #133(↓58) | -32.0% |
| 2006 | $24.7B | #75(↓23) | -13.4% |
| 2005 | $28.6B | #52(↑7) | +22.9% |
| 2004 | $23.2B | #59(↓7) | +3.8% |
| 2003 | $22.4B | #52(↓3) | +27.8% |
| 2002 | $17.5B | #49(↑7) | -14.4% |
| 2001 | $20.4B | #56(↑2) | -11.7% |
| 2000 | $23.2B | #58(↓8) | +6.5% |
| 1999 | $21.8B | #50(↑13) | +129.8% |
| 1998 | $9.5B | #63(↑27) | +93.2% |
| 1997 | $4.9B | #90(↓17) | -0.5% |
| 1996 | $4.9B | #73(↓19) | -8.4% |
| 1995 | $5.4B | #54(↑8) | +101.3% |
| 1994 | $2.7B | #62 |
その他のヘルスケア企業
よくある質問
What is Amgen Inc.'s market cap?
Amgen Inc. (AMGN) has a market capitalization of $229.5B, making it the #63 largest company in the world by market cap.
What was Amgen Inc.'s highest market cap?
Amgen Inc.'s all-time high market cap was $229.5B, reached in 2026-08-18. Its highest rank was #63 in 2026.
What sector is Amgen Inc. in?
Amgen Inc. is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in United States.
How has Amgen Inc.'s market cap changed over time?
Amgen Inc. has been tracked since 2026. Its market cap has grown by 0% from $229.5B in 2026 to $229.5B today.